<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02060357</url>
  </required_header>
  <id_info>
    <org_study_id>11/LO/0948</org_study_id>
    <nct_id>NCT02060357</nct_id>
  </id_info>
  <brief_title>Comparison of Two New Generation Drug Eluting Stents in Patients With Diabetes (OCT-DES)</brief_title>
  <acronym>OCT-DES</acronym>
  <official_title>Comparison of Two New Generation Drug Eluting Stents in Patients With Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barts &amp; The London NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Barts &amp; The London NHS Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is a comparative evaluation of re-endothelailisation of the Integrity
      Resolute zotarolimus eluting stent (Medtronic) and of the Promus Element erolimus eluting
      stent (Boston Scientific), in patients with diabetes.

      We plan to compare endothelial coverage and neointimal proliferation using OCT and compare
      this data to published results from conventional stents.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial stent coverage</measure>
    <time_frame>6 month</time_frame>
    <description>Endothelial coverage expressed as % of struts without coverage as measured by OCT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neointimal hyperplasia</measure>
    <time_frame>6 month</time_frame>
    <description>Neointimal hyperplasia (mm2) as measured by OCT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE</measure>
    <time_frame>6 months</time_frame>
    <description>death, heart failure, myocardial infarction, stroke, need for repeat revascularisation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Resolute Integrity Stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be randomised in a 1:1 ratio to receive two different types of DES</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Promus Stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be randomised in a 1:1 ratio to receive two different types of DES</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical coherence tomography</intervention_name>
    <arm_group_label>Resolute Integrity Stent</arm_group_label>
    <arm_group_label>Promus Stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Known to have diabetes

          -  Scheduled for percutaneous coronary intervention (PCI) with a stenosis suitable for
             DES implantation and OCT imaging

          -  Reference vessel diameter over 2.5mm by operator assessment.

          -  Able to understand and sign the written Informed Consent Form.

          -  Able and willing to follow the Protocol requirements.

        Exclusion Criteria:

          -  Inability to consent

          -  Cardiogenic shock

          -  Planned use of a bare metal stent

          -  LMS coronary artery disease

          -  Congestive cardiac failure or low ejection fraction (LVEF &lt;35%)

          -  Lesions unsuitable for OCT

          -  Total length of stented lesion greater than 55mm (total combination of stent lengths)

          -  Age less than 18 years or age greater than 80 years

          -  Planned surgical procedure â‰¤ 12 months post PCI procedure

          -  Patient demonstrates evidence of thrombocytopenia (platelet count &lt; 100,000/mm3)

          -  Patients with contraindications to ASA, clopidogrel, or prasogrel

          -  Patient is currently on warfarin, or possibility of treatment with warfarin during the
             following 12 months post index procedure

          -  Allergy to contrast

          -  Patients enrolled in another active clinical trial.

          -  Potential for non-compliance towards the requirements in the study protocol.

          -  Serious known concomitant disease with a life expectancy of less than one year

          -  Follow-up impossible (no fixed abode, etc)

          -  Patients with renal impairment (Creatinine &gt;200mmol/L)

          -  Subjects of childbearing potential
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anthony Mathur, FRCP FESC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barts &amp; The London NHS Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>London Chest Hospital, Barts Health NHS Trust</name>
      <address>
        <city>London</city>
        <zip>E2 9JX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2014</study_first_submitted>
  <study_first_submitted_qc>February 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2014</study_first_posted>
  <last_update_submitted>August 6, 2015</last_update_submitted>
  <last_update_submitted_qc>August 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Barts &amp; The London NHS Trust</investigator_affiliation>
    <investigator_full_name>Anthony Mathur</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>PCI</keyword>
  <keyword>Drug eluting stent</keyword>
  <keyword>OCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

